Send mail to Author

Phase I clinical study of the recombinant antibody toxin scFv(FRP5)-ETA specific for the ErbB2/HER2 receptor in patients with advanced solid malignomas (Article)

Please indicate your contact information and select, which author you want to contact.



 
  _  __     ___     _    _     ______              _____   
 | |/ //   / _ \\  | || | ||  /_   _//   ____     |  ___|| 
 | ' //   | / \ || | || | ||   -| ||-   |    \\   | ||__   
 | . \\   | \_/ || | \\_/ ||   _| ||_   | [] ||   | ||__   
 |_|\_\\   \___//   \____//   /_____//  |  __//   |_____|| 
 `-` --`   `---`     `---`    `-----`   |_|`-`    `-----`  
                                        `-`                
 


Back to frontdoor view